Industry Relationships With Pediatricians: Findings From the Open Payments Sunshine Act

BACKGROUND AND OBJECTIVES: Ties between physicians and pharmaceutical/medical device manufactures have received considerable attention. The Open Payments program, part of the Affordable Care Act, requires public reporting of payments to physicians from industry. We sought to describe payments from industry to physicians caring for children by (1) comparing payments to pediatricians to other medical specialties, (2) determining variation in payments among pediatric subspecialties, and (3) identifying the types of payment and the products associated with payments to pediatricians. METHODS: We conducted a descriptive, cross-sectional analysis of Open Payments data from January 1 to December 31, 2014. The primary outcomes included percent of physicians receiving payments, median total pay per physician, the types of payments received, and the drugs and devices associated with payments. RESULTS: There were 9 638 825 payments to physicians, totaling $1 186 217 157. There were 244 915 payments to general pediatricians and pediatric subspecialists, totaling >$32 million. The median individual payment to general pediatricians was $14.63 (interquartile range 12–20), and median total pay per general pediatrician was $89 (interquartile range 32–186). General pediatricians accounted for 1.7% of total payments, and 0.9% of the sum of payments. Developmental pediatricians had the highest percentage of pediatric physicians receiving payment, and pediatric endocrinologists received the highest median payment. Top marketed medications were for attention-deficient/hyperactivity disorder and vaccinations. CONCLUSIONS: More than 40% of pediatricians received payments from industry in 2014, a lower percentage than family physicians or internists. There was considerable variation in physician-industry ties among the pediatric subspecialties. Most payments were associated with medications that treat attention-deficient/hyperactivity disorder and vaccinations.

[1]  Thomas Pasko,et al.  Physician Characteristics and Distribution in the Us: 1999 , 1998 .

[2]  Minghua L Chen,et al.  Outpatient Visits and Medication Prescribing for US Children With Mental Health Conditions , 2015, Pediatrics.

[3]  G. Loewenstein,et al.  A social science perspective on gifts to physicians from industry. , 2003, JAMA.

[4]  David Blumenthal,et al.  A national survey of physician-industry relationships. , 2007, The New England journal of medicine.

[5]  Lisa Rosenbaum Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations. , 2015, The New England journal of medicine.

[6]  Joel Lexchin,et al.  Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review , 2010, PLoS medicine.

[7]  S. Krimsky,et al.  Conflicts of Interest and Disclosure in the American Psychiatric Association’s Clinical Practice Guidelines , 2009, Psychotherapy and Psychosomatics.

[8]  J. Kassirer A piece of my mind: financial indigestion. , 2000, JAMA.

[9]  P. Budetti,et al.  The Sunshine Act--effects on physicians. , 2013, The New England journal of medicine.

[10]  A. Kesselheim,et al.  Health Policy Basics: The Physician Payment Sunshine Act and the Open Payments Program , 2014, Annals of Internal Medicine.

[11]  A. Wazana,et al.  Physicians and the pharmaceutical industry: is a gift ever just a gift? , 2000, JAMA.

[12]  T. Stossel Has the hunt for conflicts of interest gone too far? Yes , 2008, BMJ : British Medical Journal.

[13]  S. Hill,et al.  Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry: A Cross-sectional Study of Common Conditions in the United States , 2013, PLoS medicine.

[14]  V. Moyer,et al.  Overdiagnosis: How Our Compulsion for Diagnosis May Be Harming Children , 2014, Pediatrics.

[15]  R. Steinbrook,et al.  Justifying conflicts of interest in medical journals: a very bad idea , 2015, BMJ : British Medical Journal.

[16]  Mohit Bhandari,et al.  Accuracy of conflict-of-interest disclosures reported by physicians. , 2009, The New England journal of medicine.

[17]  C. Edmiston,et al.  Accreditation Council for Continuing Medical Education Approves SHEA , 1998, Infection Control & Hospital Epidemiology.

[18]  P. Bearman,et al.  Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis , 2013, BMJ.